Further, by testing the glycolytic function with seahorse and detecting downstream metabolites of the glycolysis pathway by mass spectrometry, we found that the knockdown of ALDOA expression in tumor cells leads to a lower level of glycolytic products compared to that of control cells. Here, ALDOA is linked to neoplasm.